At UFPR, I developed new antigens for bovine tuberculosis diagnosis, from in silico selection through experimental evaluation. This work included epitope prediction and selection, peptide synthesis, and recombinant protein production.
I developed, standardized, and evaluated ELISA assays using experimental design and statistical analysis. I also contributed to the initial development of a peptide-based electrochemical immunosensor.
During my master's research at UFPR, I selected, produced, and evaluated the neutralizing activity of anti-SARS-CoV-2 IgY antibodies. I also worked on immunization, antibody purification, and in vitro neutralization assays.
My research and innovation work has contributed to 13 patent filings, and I have published four scientific articles. My background also includes microbiological and physicochemical analyses in a quality-control internship at FUNDETEC/PR.
